Acadia Pharmaceuticals Inc
ACAD
Market Cap$3.61B
Close$
$18.95
13% downside
Current Fair Value
13% downsideOvervalued by 13% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.61 Billion |
|---|---|
| Enterprise Value | $3.46 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.37 |
| Beta | 0.48 |
| Outstanding Shares | 166,808,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 15.72 |
|---|---|
| PEG | 107.01 |
| Price to Sales | 4.35 |
| Price to Book Ratio | 5.44 |
| Enterprise Value to Revenue | 3.47 |
| Enterprise Value to EBIT | 39.13 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Acadia Pharmaceuticals Inc
CEO: Uli Hacksell